BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3297557)

  • 1. Antifilarials and their mode of action.
    Subrahmanyam D
    Ciba Found Symp; 1987; 127():246-64. PubMed ID: 3297557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
    Mackenzie CD; Geary TG
    Expert Rev Anti Infect Ther; 2011 May; 9(5):497-501. PubMed ID: 21609260
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of some known antifilarials on the immune responses of Mastomys natalensis infected with Brugia malayi.
    Tyagi K; Murthy PK; Sen AB
    Indian J Med Res; 1986 Feb; 83():155-61. PubMed ID: 3710542
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in the chemotherapy of lymphatic filariasis.
    Navaratnam V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

  • 6. Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.
    von Geldern TW; Morton HE; Clark RF; Brown BS; Johnston KL; Ford L; Specht S; Carr RA; Stolarik DF; Ma J; Rieser MJ; Struever D; Frohberger SJ; Koschel M; Ehrens A; Turner JD; Hübner MP; Hoerauf A; Taylor MJ; Ward SA; Marsh K; Kempf DJ
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007159. PubMed ID: 30818326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress and challenges in the discovery of macrofilaricidal drugs.
    Geary TG; Mackenzie CD
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):681-95. PubMed ID: 21819332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Litomosoides carinii: mode of action in vitro of benzothiazole and amoscanate derivatives with antifilarial activity.
    Davies KP; Zahner H; Köhler P
    Exp Parasitol; 1989 May; 68(4):382-91. PubMed ID: 2721632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description, mechanisms and control of reactions to treatment in the human filariases.
    Ottesen EA
    Ciba Found Symp; 1987; 127():265-83. PubMed ID: 3297558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
    Halliday A; Guimaraes AF; Tyrer HE; Metuge HM; Patrick CN; Arnaud KO; Kwenti TD; Forsbrook G; Steven A; Cook D; Enyong P; Wanji S; Taylor MJ; Turner JD
    Parasit Vectors; 2014 Oct; 7():472. PubMed ID: 25338621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in research on filariasis. Chemotherapy.
    Goodwin LG
    Trans R Soc Trop Med Hyg; 1984; 78 Suppl():1-8. PubMed ID: 6382706
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro.
    Hübner MP; Martin C; Specht S; Koschel M; Dubben B; Frohberger SJ; Ehrens A; Fendler M; Struever D; Mitre E; Vallarino-Lhermitte N; Gokool S; Lustigman S; Schneider M; Townson S; Hoerauf A; Scandale I
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008427. PubMed ID: 32628671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microfilaricidal activity of ivermectin in vitro and in vivo.
    Devaney E; Howells RE
    Tropenmed Parasitol; 1984 Mar; 35(1):47-49. PubMed ID: 6546818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antifilarial activity of a marine red alga, Botryocladia leptopoda, against experimental infections with animal and human filariae.
    Lakshmi V; Kumar R; Gupta P; Varshney V; Srivastava MN; Dikshit M; Murthy PK; Misra-Bhattacharya S
    Parasitol Res; 2004 Aug; 93(6):468-74. PubMed ID: 15243801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
    Sashidhara KV; Singh SP; Misra S; Gupta J; Misra-Bhattacharya S
    Eur J Med Chem; 2012 Apr; 50():230-5. PubMed ID: 22348826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifilarial activity of levamisole on Breinlia sergenti and its comparison with diethylcarbamazine.
    Zaman V; Natarajan PN
    J Trop Med Hyg; 1973 May; 76(5):126-30. PubMed ID: 4712298
    [No Abstract]   [Full Text] [Related]  

  • 19. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.
    Hoerauf A
    Curr Opin Infect Dis; 2008 Dec; 21(6):673-81. PubMed ID: 18978537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.